Applied Protein Technology Raises Hundreds of Millions in Series B Funding
Shanghai-based Applied Protein Technology (APT Bio), a biotech company focused on mass spectrometry multi-omics precision...
AI
Insilico Medicine Closes USD95m Series D Financing to Advance AI Drug Discovery
Insilico Medicine, a Hong Kong-based artificial intelligence (AI)-driven drug discovery company, announced the closure of...
Pica Partners with BrainCo to Launch ADHD Product in China
Shanghai-based primary healthcare digital platform Pica, developed by Wuxi AppTec in 2016, has partnered with...
HitGen and LoQus23 Therapeutics Partner on DNA Encoded Library for Neurodegeneration
China-based HitGen Inc. (SHA: 688222) announced a strategic partnership with UK-headquartered LoQus23 Therapeutics Ltd, leveraging...
Yunnan Baiyao and Huawei Partner on AI-Driven Drug Development
Yunnan Baiyao Group Co., Ltd (SHE: 000538), a Kunming-based pharmaceutical firm, has entered into a...
Fermion Secures Series B Financing to Advance AI-Driven Drug Development
Guangzhou-based AI biotech Fermion has raised over RMB100 million ($14.8 million) in a Series B...
Helixon Secures RMB 500 Million in Series A Round to Advance AI-Driven Drug Development
Beijing-based Helixon, an artificial intelligence (AI)-empowered pharmaceutical company, has reportedly secured RMB 500 million (USD...
Shenzhen AXBio Closes USD 100 Million Series B Round for Sequencing Tech Expansion
Shenzhen-based fourth-generation sequencing company Anxuyuan Biotechnology (shenzhen) Company Limited (AXBio) has reportedly secured close to...
Tianhe-2 Supercomputer Aids Drug Discovery with Deep-Learning Biosynthetic Tool
China’s Tianhe-2 supercomputer, ranked among the top-10 fastest computers globally, has demonstrated potential in enhancing...
MegaRobo Secures USD 300 Million in Series C Round Led by Goldman Sachs
Beijing-based MegaRobo Technologies, a company applying robotics and artificial intelligence (AI) in the life sciences...